As of 2024-12-13, the Relative Valuation of Abbott Laboratories (ABT) is 130.73 USD. This relative valuation is based on P/E multiples. With the latest stock price at 113.38 USD, the upside of Abbott Laboratories based on Relative Valuation is 15.3%.
The range of the Relative Valuation is 117.10 - 150.29 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.3x - 41.3x | 38.8x |
| Forward P/E multiples | 30.1x - 38.6x | 34.0x |
| Fair Price | 117.10 - 150.29 | 130.73 |
| Upside | 3.3% - 32.6% | 15.3% |
| Date | P/E |
| 2024-12-13 | 34.11 |
| 2024-12-12 | 34.24 |
| 2024-12-11 | 34.33 |
| 2024-12-10 | 34.74 |
| 2024-12-09 | 34.56 |
| 2024-12-06 | 34.77 |
| 2024-12-05 | 34.76 |
| 2024-12-04 | 34.88 |
| 2024-12-03 | 34.97 |
| 2024-12-02 | 35.13 |
| 2024-11-29 | 35.72 |
| 2024-11-27 | 35.77 |
| 2024-11-26 | 35.48 |
| 2024-11-25 | 35.53 |
| 2024-11-22 | 35.42 |
| 2024-11-21 | 35.27 |
| 2024-11-20 | 34.87 |
| 2024-11-19 | 35.23 |
| 2024-11-18 | 35.30 |
| 2024-11-15 | 34.86 |
| 2024-11-14 | 34.60 |
| 2024-11-13 | 34.81 |
| 2024-11-12 | 35.02 |
| 2024-11-11 | 35.13 |
| 2024-11-08 | 35.07 |
| 2024-11-07 | 34.68 |
| 2024-11-06 | 35.13 |
| 2024-11-05 | 35.41 |
| 2024-11-04 | 35.38 |
| 2024-11-01 | 35.67 |
| 2024-10-31 | 34.10 |
| 2024-10-30 | 34.42 |
| 2024-10-29 | 34.11 |
| 2024-10-28 | 34.31 |
| 2024-10-25 | 34.35 |
| 2024-10-24 | 35.05 |
| 2024-10-23 | 35.19 |
| 2024-10-22 | 34.92 |
| 2024-10-21 | 35.19 |
| 2024-10-18 | 35.91 |
| 2024-10-17 | 35.46 |
| 2024-10-16 | 35.44 |
| 2024-10-15 | 34.90 |
| 2024-10-14 | 35.26 |
| 2024-10-11 | 34.92 |
| 2024-10-10 | 34.77 |
| 2024-10-09 | 34.87 |
| 2024-10-08 | 34.48 |
| 2024-10-07 | 34.09 |
| 2024-10-04 | 33.88 |